Phase-dependent trends in the prevalence of myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) related to long COVID: A criteria-based retrospective study in Japan

• Published in: PloS one Vol. 19; no. 12; p. e0315385
• Main Authors: Morita, Satoru, Tokumasu, Kazuki, Otsuka, Yuki, Honda, Hiroyuki, Nakano, Yasuhiro, Sunada, Naruhiko, Sakurada, Yasue, Matsuda, Yui, Soejima, Yoshiaki, Ueda, Keigo, Otsuka, Fumio
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 09.12.2024; Public Library of Science (PLoS)
• Subjects: Adult; Aged; Autoimmune diseases; Biology and Life Sciences; Brain; Chronic fatigue syndrome; Coronaviruses; COVID-19; COVID-19 - epidemiology; Criteria; Disease; Drinking behavior; Encephalomyelitis; Ethics; Fatigue; Fatigue Syndrome, Chronic - epidemiology; Female; Females; Ferritin; Fog; Hospitals; Humans; Japan - epidemiology; Long COVID; Male; Medical records; Medicine and Health Sciences; Middle Aged; Patients; Post-Acute COVID-19 Syndrome; Prevalence; Questionnaires; Retrospective Studies; SARS-CoV-2 - isolation & purification; Trends; Vaccination; Japan; United States > US
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0315385

The characteristics of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) related to COVID-19 have remained uncertain. To elucidate the clinical trend of ME/CFS induced by long COVID, we examined data for patients who visited our outpatient clinic established in a university hospital during the period from Feb 2021 to July 2023. Long COVID patients were classified into two groups, an ME/CFS group and a non-ME/CFS group, based on three diagnostic criteria. The prevalence of ME/CFS in the long COVID patients was 8.4% (62 of 739 cases; female: 51.6%) and factors related to ME/CFS were severe illness, smoking and alcohol drinking habits, and fewer vaccinations. The frequency of ME/CFS decreased from 23.9% in the Preceding period to 13.7% in the Delta-dominant period and to 3.3% in the Omicron-dominant period. Fatigue and headache were commonly frequent complaints in the ME/CFS group, and the frequency of poor concentration in the ME/CFS group was higher in the Omicron period. Serum ferritin levels were significantly higher in female patients in the ME/CFS group infected in the Preceding period. In the ME/CFS group, the proportion of patients complaining of brain fog significantly increased from 22.2% in the Preceding period to 47.9% in the Delta period and to 81.3% in the Omicron period. The percentage of patients who had received vaccination was lower in the ME/CFS group than the non-ME/CFS group over the study period, whereas there were no differences in the vaccination rate between the groups in each period. The proportion of long COVID patients who developed ME/CFS strictly diagnosed by three criteria was lower among patients infected in the Omicron phase than among patients infected in the other phases, while the proportion of patients with brain fog inversely increased. Attention should be paid to the variant-dependent trends of ME/CFS triggered by long COVID (300 words).